3D Bioprinting Market Report 2024: Strategies And Recent Developments

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2034

The Business Research Company offers in-depth market insights through 3D Bioprinting Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The 3d bioprinting market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.9 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.

The 3d bioprinting market size is expected to see exponential growth in the next few years. It will grow to $4.15 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%. The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population . Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=5341&type=smp

Market Segmentation:
The main types of components in 3D bioprinting are 3D bioprinters and bio-inks. 3D bioprinters use three-dimensional technology in combination with biocompatible materials to replicate body parts. It is used for bioprinting of tissue, bone, organs, blood vessels tissue, and biomedical parts. The different types of materials include living cells, hydrogels, extracellular matrices, and others. 3D bioprinting is used in research applications, clinical applications, and others and is implemented in several verticals such as research organizations and academic institutes, biopharmaceutical companies, hospitals, and others.

Major Driver - Increased Government And Private Funding Fuels The Growth Of 3D Bioprinting Market
Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2021, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 in June 2020 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration.

Competitive Landscape:
Major companies operating in the 3d bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/3d-bioprinting-global-market-report

Top Trend - Next-Generation Of Bioprinters For Enhanced Precision
Major companies operating in the 3D bioprinting market are introducing next-generation bioprinters that are cost-effective such as the BIO MDX Series to increase precision. The BIO MDX Series is the latest generation of bioprinters, designed for high-throughput fabrication and precision 3D bioprinting in biomedical manufacturing. For instance, in March 2021, Cognex Corporation, a Sweden-based bioconvergence company launched the BIO MDX Series, a next-generation of bioprinters optimized for high-throughput biofabrication and precision 3D bioprinting in biomedical manufacturing. This development comes as 3D bioprinting becomes a preferred method for researchers in tissue engineering and regenerative medicine, highlighting the need for enhanced automation, precision, and reproducibility. The BIO MDX series, with up to six printheads and integrated nanoliter and picoliter dispensing channels, caters to advanced cell-based technologies.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. 3D Bioprinting Market Characteristics
3. 3D Bioprinting Market Trends And Strategies
4. 3D Bioprinting Market - Macro Economic Scenario
5. 3D Bioprinting Market Size And Growth
…..
27. 3D Bioprinting Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.